Oregon Health & Sciences University - Knight Cancer Institute - Center for Hematologic Malignancies is a clinical research site located in Portland, Oregon, United States 97239.
Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.
Oregon Health & Sciences University - Knight Cancer Institute - Center for Hematologic Malignancies has participated in 1 clinical trials.
Therapeutic areas: Acute Myeloid Leukemia (AML).
Sponsors: Sumitomo Pharma America, Inc..
Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Oregon Health & Sciences University - Knight Cancer Institute - Center for Hematologic Malignancies has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Oregon Health & Sciences University - Knight Cancer Institute - Center for Hematologic Malignancies has 1 clinical trials on record. Their work covers Acute Myeloid Leukemia (AML).
Oregon Health & Sciences University - Knight Cancer Institute - Center for Hematologic Malignancies has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.